For example, Lynch syndrome is often associated with pathogenic variants in MSH2, while pathogenic variants in BRCA1 and BRCA2 are commonly associated with hereditary breast and ovarian cancer [15, 18, 19]. This evidence concerns the gene MSH2 and Lynch syndrome.